Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
Background Immune checkpoint inhibitors (ICIs) provide significant survival benefits in non-small cell lung cancer (NSCLC). Nevertheless, while some patients obtain a prolonged benefit, a non-negligible fraction of patients experiences an ultrarapid disease progression. Identifying specific molecula...
Main Authors: | Andrea Botticelli, Irene Terrenato, Marco Mazzotta, Mario Occhipinti, Daniele Marinelli, Stefano Scalera, Francesca Sperati, Francesco Rizzo, Giorgia Scafetta, Arianna Di Napoli, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Silvia Carpano, Patrizia Vici, Francesca De Nicola, Ludovica Ciuffreda, Frauke Goeman, Andrea Vecchione, Marcello Maugeri-Saccà |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/2/e000946.full |
Similar Items
-
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
by: Marco Mazzotta, et al.
Published: (2019-02-01) -
Cancer patients and coronavirus disease 2019: evidence in context
by: Maddalena Barba, et al.
Published: (2020-08-01) -
Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
by: Frauke Goeman, et al.
Published: (2020-12-01) -
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
by: Matteo Pallocca, et al.
Published: (2018-09-01) -
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
by: Antonino Grassadonia, et al.
Published: (2021-07-01)